
南美洲和中美洲医用酶技术市场预测至 2028 年 - COVID-19 影响和酶类型(消化酶、溶栓酶、水解酶和核酸内切酶)的区域分析;应用(疾病治疗、诊断工具、生物医学研究等)
No. of Pages: 146 | Report Code: TIPRE00025042 | Category: Life Sciences
No. of Pages: 146 | Report Code: TIPRE00025042 | Category: Life Sciences
酶是植物、动物和微生物的活细胞中产生的蛋白质。所有生物体都需要酶来生长以及产生和利用生命所必需的能量。在活细胞中,酶充当催化剂,加速控制生命过程的化学反应。一百多年来,酶一直是重要的工业产品。然而,潜在的应用范围正在迅速扩大。随着重组 DNA 技术的出现,大量生产以前稀有的酶已成为可能,从而降低了成本。此外,在药品制造中,制造手性纯化合物的愿望正在带来新的机遇。技术进步促进了酶在越来越广泛的工艺条件下的使用。
因此,研究和开发活动的显着增加预计将在未来几年对医用酶技术产生巨大需求,预计这将进一步推动医用酶技术市场。
南美洲和中美洲的 COVID-19 病例正在增加。随着第二波COVID-19的爆发,拉丁美洲国家的病例数量有所增加。现在,国家正在日益扩大其临床服务以抗击新型冠状病毒。尽管存在这种影响,该地区的生物技术行业在抗击病毒方面却几乎没有采取任何行动,项目的缺乏暴露了该行业的脆弱性。有一些不相关的自主项目正在进行,但它们是彼此独立发生的,这意味着没有强大的生物技术网络。全球正在进行的数百个 COVID-19 疫苗或药物项目中的一小部分是在一个拥有超过 6.52 亿居民的地区和许多中等收入国家中进行的。目前,拉丁美洲只有 6 个独立生物技术项目正在研究 COVID-19,要么寻找疫苗,要么寻找治疗新型冠状病毒的方法。它们都不会进行临床试验。
南美洲和中美洲的医用酶技术市场预计将从2021年的2.793亿美元增长到2028年的4.121亿美元;预计 2021 年至 2028 年复合年增长率为 5.7%。生物制药是制药和生物技术行业不断增长的业务领域之一。自 1982 年推出以来,生物制药彻底改变了多种疾病的治疗方法,并且越来越多地应用于几乎所有医学分支。尽管需要投入大量时间和资金,生物制药市场仍在快速增长。
从酶类型来看,2020年南美洲和中美洲医用酶技术市场中水解酶领域占据最大份额。从应用领域来看,疾病治疗领域占据最大份额。 2020年南美洲和中美洲医用酶技术市场。
准备本南美洲和中美洲医用酶技术市场报告时提到的一些主要一手和二手来源是公司网站、年度报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司包括 Merck Kgaa、Thermo Fisher Scientific Inc.、Novozymes、Takeda Pharmaceutical Company Limited、Agilent Technologies, Inc.、Genzyme Corporation、Asahi Kasei Corporation、Promega Corporation、Cytiva 和 Amano Enzyme Inc.
按酶类型
按申请
按国家/地区
Strategic insights for South and Central America Medical Enzyme Technology involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 279.3 Million |
Market Size by 2028 | US$ 412.1 Million |
Global CAGR (2021 - 2028) | 5.7% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 酶类型
|
Regions and Countries Covered | 南美洲和中美洲
|
Market leaders and key company profiles |
The regional scope of South and Central America Medical Enzyme Technology refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South and Central America Medical Enzyme Technology Market is valued at US$ 279.3 Million in 2021, it is projected to reach US$ 412.1 Million by 2028.
As per our report South and Central America Medical Enzyme Technology Market, the market size is valued at US$ 279.3 Million in 2021, projecting it to reach US$ 412.1 Million by 2028. This translates to a CAGR of approximately 5.7% during the forecast period.
The South and Central America Medical Enzyme Technology Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Medical Enzyme Technology Market report:
The South and Central America Medical Enzyme Technology Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South and Central America Medical Enzyme Technology Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South and Central America Medical Enzyme Technology Market value chain can benefit from the information contained in a comprehensive market report.